PharmCo III ApS: Financial statements 2021
CVR: 41103647
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
PharmCo III ApS (CVR 41103647) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -26,162 and a net result of DKK 20,524,284 compared with DKK 18,571,189 the year before. Equity in the 2021 report amounted to DKK 39,027,253. The solvency ratio was 40.5%.
- Revenue
- DKK 0
- Gross Profit
- DKK -26,162
- Profit/Loss
- DKK 20,524,284
- Equity
- DKK 39,027,253
- Total Assets
- DKK 96,264,482
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | -26 t. | 20.5 mio. | 39 mio. | - |
| 2020 | - | -35 t. | 18.6 mio. | 18.2 mio. | - |
Official annual report
Find more companies like PharmCo III ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
PharmCo III ApS has published its annual report for 2020. Gross profit came to DKK -35,000, and the net result was DKK 18,571,189.
About PharmCo III ApS
PharmCo III ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -33,000 and a net result of DKK 18,532,000 compared with DKK 13,877,698 the year before. Equity in the 2025 report amounted to DKK 100,696,000.